Method for manufacturing of drug-releasing stent coated with titanium-oxide thin film

Inactive Publication Date: 2011-01-13
IND FOUND OF CHONNAM NAT UNIV
View PDF5 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0009]An object of the present invention is to provide a method for manufacturing a drug-releasing stent capable of expanding a narrowed blood vessel, releasing a drug in a sustained manner and remaining stable for a long time in the body without cytotoxicity.
[0012]Thus manufactured drug-releasing stent remains stable for a long time in the blood vessel without cytotoxicity, provides superior blood compatibility, and releases a drug into the bloodstream in a sustained manner.

Problems solved by technology

Although the introduction of metal-based stents avoids acute vessel closure and reduces restenosis after balloon angioplasty, restenosis in the stent resulting from neointimal hyperplasia during the restoration of the damaged blood vessel is becoming a problem.
However, the safety of the organic compound coated film has not been confirmed yet in terms of blood compatibility, cytotoxicity, or the like.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for manufacturing of drug-releasing stent coated with titanium-oxide thin film
  • Method for manufacturing of drug-releasing stent coated with titanium-oxide thin film
  • Method for manufacturing of drug-releasing stent coated with titanium-oxide thin film

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Titanium Dioxide and Nitrogen-Doped Titanium Oxide (TiO2-xNx) Thin Films

[0052]A stent was fixed in a vacuum chamber connected to a radio frequency (RF) plasma generator and a vacuum pump using a titanium wire, as illustrated in FIG. 1. The temperature inside the plasma chamber was maintained at 400° C. In order to improve adhesion between the stent and a thin film, the surface of the stent was cleaned by a plasma pretreatment process by flowing argon and oxygen, prior to the coating of the thin film. After adding titanium isopropoxide in a bubbler, the titanium isopropoxide was mixed with oxygen, a reactant gas, and introduced into the reaction chamber using argon as a carrier gas, while maintaining the temperature of the bubbler at 50° C. Then, a plasma was generated for 4 hours to coat a titanium dioxide thin film on the surface of the stent. The carrier gas argon was supplied at a rate of 100 sccm, and the reactant gas oxygen was supplied at a rate of 20 sccm. Vari...

example 2

Modification of Titanium Oxide Thin Film with Hydroxyl Groups

[0053]In order to chemically attach a drug on the surface of the coated titanium dioxide, the titanium oxide should have functional groups that can chemically bind to the functional groups of the drug molecules. Accordingly, the surface of titanium dioxide was modified using a low-temperature plasma and distilled water (H2O) in order to introduce hydroxyl (—OH) groups thereon. The titanium dioxide coated stent was fixed in a tubular low-temperature plasma reactor made of Pyrex. After filling triple distilled water in a bubbler, steam was supplied into the plasma reactor at a rate of 10 sccm. The titanium dioxide thin film was modified for 10 minutes via a low-temperature plasma process while varying discharge power from 10 to 100 W. The result of surface modification was confirmed by measuring a contact angle.

example 3

Manufacture of α-Lipoic Acid Attached Stent

[0054]A two-neck round flask connected to a reflux condenser was purged with nitrogen, and the surface-modified unit stent, α-lipoic acid (0.5 g), distilled water (5 mL) and strong sulfuric acid (20 μL) were added thereto. The mixture was stirred for 1 hour under a nitrogen atmosphere while maintaining the temperature at 55° C. Upon completion of the reaction, the stent was recovered, washed 3 times with ethanol, washed 3 times with flowing triple distilled water, blown with air, and dried in a desiccator.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Timeaaaaaaaaaa
Timeaaaaaaaaaa
Login to View More

Abstract

Disclosed is a method for manufacturing a drug-releasing stent, including: coating a titanium dioxide or nitrogen-doped titanium dioxide thin film on a metal stent; and attaching a drug on the surface of the titanium oxide thin film. More specifically, the method for manufacturing a drug-releasing stent includes: coating a titanium dioxide or nitrogen-doped titanium dioxide thin film on a metal stent, which can be inserted into the blood vessel, by plasma enhanced chemical vapor deposition (PECVD); modifying the surface of the titanium oxide thin film with hydroxyl groups by low-temperature plasma; and chemically attaching a drug such as an antithrombotic drug or a neointimal hyperplasia inhibitor, so that the drug may be released in the blood vessel in a sustained manner.

Description

CROSS-REFERENCE(S) TO RELATED APPLICATIONS[0001]The present invention claims priority of Korean Patent Application No. 10-2009-0062571, filed on Jul. 9, 2009, which is incorporated herein by reference.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention relates to a drug-releasing stent which is inserted into a narrowed blood vessel to dilate the blood vessel and slowly releases a drug in the blood vessel, which is manufactured by coating the surface of the stent with titanium oxide, modifying the surface of the coated film, and chemically attaching the drug thereto.[0004]2. Description of Related Art[0005]A stent is a medical device inserted into a blood vessel narrowed due to various diseases to dilate the blood vessel and improve blood circulation. In general, the stent is inserted in heart blood vessels, aorta or brain blood vessels along with a balloon catheter, and the balloon is inflated to expand the coronary passage. As the balloon inflates,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61F2/82C23C16/50A61F2/86
CPCA61F2/86A61F2/91A61F2250/0067A61L31/022A61L31/088A61F2/82A61L2300/41A61L2300/416A61L2300/42C23C16/405C23C16/56A61L31/16A61L27/04A61L27/30A61L27/54
InventorCHO, DONG LYUNSONG, SUN-JUNGJEONG, MYUNG HOKIM, KYOUNG SEOKPARK, YU JEONG
OwnerIND FOUND OF CHONNAM NAT UNIV